BTB01303
BTB01303 is a (glutamate release) inhibitor. Cancer cells release high levels of (glutamate), which disrupts normal bone turnover and may lead to cancer-induced bone pain. BTB01303 has the potential to improve cancer-induced bone pain[1].
Product Specifications
CAS Number
652129-89-0
UNSPSC
12352005
Target
MGluR
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/btb01303.html
Solubility
10 mM in DMSO
Smiles
ClC1=CC(/C=N/C2=CC=C3OCOCC3=C2)=C(O)C(Cl)=C1
Molecular Formula
C15H11Cl2NO3
Molecular Weight
324.16
References & Citations
[1]Fazzari J, et al. Inhibitors of glutamate release from breast cancer cells; new targets for cancer-induced bone-pain. Sci Rep. 2015 Feb 11;5:8380.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15356574 1 Vial
Lentiviral human ERICH3 sgRNA gene knockout kit - Lentiviral human ERICH3 sgRNA gene knockout kit (25)
Sign In for Pricing
View Details 035236-ML490 100 µL
ESR1 isoform4, ID (ESR1, ESR, NR3A1, Estrogen receptor, ER-alpha, Estradiol receptor, Nuclear receptor subfamily 3 group A member 1) (MaxLight 490) discontinued
Sign In for Pricing
View Details MBS1364111-01 0.5 mg (E-Coli)
Recombinant Arabidopsis thaliana Serine/threonine-protein kinase ATM (ATM) , partial
Sign In for Pricing
View Details MBS1364111-02 0.05 mg (Baculovirus)
Recombinant Arabidopsis thaliana Serine/threonine-protein kinase ATM (ATM) , partial
Sign In for Pricing
View Details MBS1364111-03 0.5 mg (Yeast)
Recombinant Arabidopsis thaliana Serine/threonine-protein kinase ATM (ATM) , partial
Sign In for Pricing
View Details